Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Two series of factor Xa inhibitors claimed by Boehringer Ingelheim

March 22, 2004

New dabigatran prodrugs designed by Boehringer Ingelheim researchers

March 22, 2004

Antithrombotic effects of razaxaban in healthy volunteers

March 16, 2004

Antithrombotic effects of DX-9065a in patients with acute coronary syndrome

March 16, 2004

Effective prevention of stroke and embolism with ximelagatran after atrial fibrillation

March 16, 2004

Targeting thrombosis with plasma carboxypeptidase B inhibitors

March 12, 2004

BioTie Therapies and Aventis sign agreement for new heparin-like drug

March 11, 2004

European approval for Advate

March 5, 2004

Recommended approval in Europe for TachoSil

March 2, 2004

NovoSeven approved in Europe for factor VII deficiency and thrombasthenia

Feb. 23, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...